{"mainPropery":{"diseaseId":2125,"diseaseName":"Glycogen storage disease type 13","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/2125/glycogen-storage-disease-type-13","synonyms":["GSD13","Glycogen storage disease 13","Enolase-beta deficiency","Enolase 3 deficiency"],"synonyms-with-source":[{"name":"GSD13"},{"name":"Glycogen storage disease 13"},{"name":"Enolase-beta deficiency"},{"name":"Enolase 3 deficiency"}],"identifiers":[{"identifierType":"OMIM","identifierId":"612932"},{"identifierType":"ORPHANET","identifierId":"99849"},{"identifierType":"UMLS","identifierId":"C2752027"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":138,"resourceName":"Metabolic Support UK","abbreviation":"","address1":"5 Hilliards Court","address2":"Sandpiper Way","address3":"Chester Business Park","address4":"","address5":"","city":"Chester","state":"","zip":"CH4 9QP","country":"United Kingdom","phone":"0845 241 2173","tty":"","tollFree":"0800 652 3181 ","fax":"","email":"https://www.metabolicsupportuk.org/contact-us","url":"https://www.metabolicsupportuk.org","freeText":""},{"resourceID":302,"resourceName":"Association for Glycogen Storage Disease UK","abbreviation":"AGSD-UK","address1":"PO Box 1232","address2":"Bristol","address3":"BS48 9DD","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"0300 123 2790","tty":"","tollFree":"","fax":"","email":"https://agsd.org.uk/contact/message-us2/","url":"http://www.agsd.org.uk/","freeText":""},{"resourceID":4278,"resourceName":"International Association for Muscle Glycogen Storage Disease","abbreviation":"IamGSD","address1":"746 4th Avenue","address2":"","address3":"","address4":"","address5":"","city":"San Francisco","state":"CA","zip":"94118","country":"United States","phone":"","tty":"","tollFree":"","fax":"","email":"info@iamgsd.org","url":"https://www.iamgsd.org/","freeText":"Contact form: https://www.iamgsd.org/contact-us"}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/612932' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?itool=omim_Detailed&DbFrom=omim&Cmd=Link&LinkName=omim_pubmed_calculated&IdsFromResult=612932' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Glycogen storage disease type 13. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C2752027' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=99849' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:612932' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6246,"questionText":"What is glycogen storage disease type 13?","answerText":"<strong>Glycogen storage disease type 13</strong> (GSD13), also known as &#946;-enolase deficiency, is&nbsp;an inherited disease of the <a href=\"http://www.nlm.nih.gov/medlineplus/tutorials/muscles/op309104.pdf\" target=_blank>muscles</a>.&nbsp; The muscles of an affected individual are not able to produce enough energy to function properly, causing muscle weakness and pain.&nbsp; GSD13 is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=_blank>mutations</a>) in the <a href=\"http://omim.org/entry/131370\" target=_blank>ENO3</a> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> pattern.[5281]","dateModified":"2012-06-24T23:37:00"},"basicQuestions":[{"questionId":6248,"questionText":"What are the signs and symptoms of glycogen storage disease type 13?","answerText":"Glycogen storage disease type 13 causes muscle pain (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003178.htm\" target=_blank>myalgia</a>).&nbsp; Individuals with GSD13 also experience exercise intolerance, which means they have difficulty exercising&nbsp;because they may have muscle weakness and tire easily.[5281]","dateModified":"2012-06-24T23:37:00","resourceClassificationName":"Symptoms","references":[{"referenceId":5281,"authors":"Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N","articleTitle":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","bookWebsiteJournalTitle":"Annals of Neurology","date":"2001","volume":"50","pages":"202-207","url":"http://www.ncbi.nlm.nih.gov/pubmed/11506403","dateAccessed":"2012-06-20T00:00:00"}]},{"questionId":6247,"questionText":"What causes glycogen storage disease type 13?","answerText":"Glycogen storage disease type 13 (GSD13)&nbsp;is caused by changes (mutations) in the <a href=\"http://www.omim.org/entry/131370\" target=_blank>ENO3</a> gene.&nbsp; <a href=\"http://www.merriam-webster.com/medlineplus/glycogen\" target=_blank>Glycogen</a> is a substance that is stored in muscle tissue and is used as an important source of energy for the muscles during movement and exercise.&nbsp; The ENO3 gene makes a chemical called enolase, which is an <a href=\"http://www.merriam-webster.com/medlineplus/enzyme\" target=_blank>enzyme</a> that helps the muscles use glycogen for energy.&nbsp;&nbsp;In GSD13, the ENO3 genes do not work properly such that the body cannot make enolase, and as a result, the muscles do not have enough energy to work properly.[5281]","dateModified":"2012-06-24T23:42:00","resourceClassificationName":"Cause","references":[{"referenceId":5281,"authors":"Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N","articleTitle":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","bookWebsiteJournalTitle":"Annals of Neurology","date":"2001","volume":"50","pages":"202-207","url":"http://www.ncbi.nlm.nih.gov/pubmed/11506403","dateAccessed":"2012-06-20T00:00:00"}]},{"questionId":6249,"questionText":"How is glycogen storage disease type 13 diagnosed?","answerText":"Glycogen storage disease type 13 is diagnosed by taking a sample of muscle tissue (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003924.htm\" target=_blank>muscle biopsy</a>) to determine if there is enough of the chemical enolase working in the muscle cells.&nbsp; Genetic testing can also be done to look for changes (mutations) in the ENO3 gene.[5281]","dateModified":"2012-06-24T23:38:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":5281,"authors":"Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N","articleTitle":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","bookWebsiteJournalTitle":"Annals of Neurology","date":"2001","volume":"50","pages":"202-207","url":"http://www.ncbi.nlm.nih.gov/pubmed/11506403","dateAccessed":"2012-06-20T00:00:00"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12259,"relatedDiseaseName":"Glycogen storage disease","relation":"Parent","isRare":false,"hasGardPage":false}],"gardCases":[{"caseId":35582,"abbreviatedInquiry":"I would like to know the background, physical presentation, and diagnostic tests for glycogen storage disease type 13.&nbsp; I am particularly interested in learning if hypoglycemia is part of this disease.","caseQuestions":[{"questionId":6246,"questionText":"What is glycogen storage disease type 13?","answerText":"<strong>Glycogen storage disease type 13</strong> (GSD13), also known as &#946;-enolase deficiency, is&nbsp;an inherited disease of the <a href=\"http://www.nlm.nih.gov/medlineplus/tutorials/muscles/op309104.pdf\" target=_blank>muscles</a>.&nbsp; The muscles of an affected individual are not able to produce enough energy to function properly, causing muscle weakness and pain.&nbsp; GSD13 is caused by changes (<a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=_blank>mutations</a>) in the <a href=\"http://omim.org/entry/131370\" target=_blank>ENO3</a> gene and is inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> pattern.[5281]","dateModified":"2012-06-24T23:37:00","references":[{"referenceId":5281,"authors":"Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N","articleTitle":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","bookWebsiteJournalTitle":"Annals of Neurology","date":"2001","volume":"50","pages":"202-207","url":"http://www.ncbi.nlm.nih.gov/pubmed/11506403","dateAccessed":"2012-06-20T00:00:00"}]},{"questionId":6247,"questionText":"What causes glycogen storage disease type 13?","answerText":"Glycogen storage disease type 13 (GSD13)&nbsp;is caused by changes (mutations) in the <a href=\"http://www.omim.org/entry/131370\" target=_blank>ENO3</a> gene.&nbsp; <a href=\"http://www.merriam-webster.com/medlineplus/glycogen\" target=_blank>Glycogen</a> is a substance that is stored in muscle tissue and is used as an important source of energy for the muscles during movement and exercise.&nbsp; The ENO3 gene makes a chemical called enolase, which is an <a href=\"http://www.merriam-webster.com/medlineplus/enzyme\" target=_blank>enzyme</a> that helps the muscles use glycogen for energy.&nbsp;&nbsp;In GSD13, the ENO3 genes do not work properly such that the body cannot make enolase, and as a result, the muscles do not have enough energy to work properly.[5281]","dateModified":"2012-06-24T23:42:00","resourceClassificationName":"Cause","references":[{"referenceId":5281,"authors":"Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N","articleTitle":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","bookWebsiteJournalTitle":"Annals of Neurology","date":"2001","volume":"50","pages":"202-207","url":"http://www.ncbi.nlm.nih.gov/pubmed/11506403","dateAccessed":"2012-06-20T00:00:00"}]},{"questionId":6248,"questionText":"What are the signs and symptoms of glycogen storage disease type 13?","answerText":"Glycogen storage disease type 13 causes muscle pain (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003178.htm\" target=_blank>myalgia</a>).&nbsp; Individuals with GSD13 also experience exercise intolerance, which means they have difficulty exercising&nbsp;because they may have muscle weakness and tire easily.[5281]","dateModified":"2012-06-24T23:37:00","resourceClassificationName":"Symptoms","references":[{"referenceId":5281,"authors":"Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N","articleTitle":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","bookWebsiteJournalTitle":"Annals of Neurology","date":"2001","volume":"50","pages":"202-207","url":"http://www.ncbi.nlm.nih.gov/pubmed/11506403","dateAccessed":"2012-06-20T00:00:00"}]},{"questionId":6249,"questionText":"How is glycogen storage disease type 13 diagnosed?","answerText":"Glycogen storage disease type 13 is diagnosed by taking a sample of muscle tissue (<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003924.htm\" target=_blank>muscle biopsy</a>) to determine if there is enough of the chemical enolase working in the muscle cells.&nbsp; Genetic testing can also be done to look for changes (mutations) in the ENO3 gene.[5281]","dateModified":"2012-06-24T23:38:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":5281,"authors":"Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N","articleTitle":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","bookWebsiteJournalTitle":"Annals of Neurology","date":"2001","volume":"50","pages":"202-207","url":"http://www.ncbi.nlm.nih.gov/pubmed/11506403","dateAccessed":"2012-06-20T00:00:00"}]},{"questionId":6250,"questionText":"Is hypoglycemia associated with glycogen storage disease type 13?","answerText":"Unfortunately, because glycogen storage disease type 13 is very rare, there is limited information about the associated features of this condition.&nbsp; However, the first individual known to have GSD13 did not have <a href=\"http://www.merriam-webster.com/medlineplus/hypoglycemia\" target=_blank>hypoglycemia</a>.[5281]","dateModified":"2012-06-24T23:39:00","references":[{"referenceId":5281,"authors":"Comi GP, Fortunato F, Lucchiari S, Bordoni A, Prelle A, Jann S, Keller A, Ciscato P, Galbiati S, Chiveri L, Torrente Y, Scarlato G, Bresolin N","articleTitle":"Beta-enolase deficiency, a new metabolic myopathy of distal glycolysis","bookWebsiteJournalTitle":"Annals of Neurology","date":"2001","volume":"50","pages":"202-207","url":"http://www.ncbi.nlm.nih.gov/pubmed/11506403","dateAccessed":"2012-06-20T00:00:00"}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":6254,"phenoTypeName":"Adult onset","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":10933,"phenoTypeName":"Elevated serum creatine kinase","percentRanges":"-"},{"phenoTypeId":6230,"phenoTypeName":"Exercise intolerance","percentRanges":"-"},{"phenoTypeId":4909,"phenoTypeName":"Increased muscle glycogen content","percentRanges":"-"},{"phenoTypeId":3980,"phenoTypeName":"Myalgia","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Glycogen_storage_disease_type_13"}